| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 09/12/2002 | DE10109855A1 Polypeptide eines p53-Protein-spezifischen murinen alpha/beta T-Zell Rezeptors, diese kodierende Nukleinsäuren und deren Verwendung Polypeptide of a p53 protein specific murine alpha / beta T-cell receptor nucleic acids encoding these, and their use |
| 09/12/2002 | DE10109854A1 Polypeptide eines hdm2-Protein spezifischen murinen alpha/beta T-Zell Rezeptors, diese kodierende Nukleinsäuren und deren Verwendung Polypeptides of hdm2 protein specific murine alpha / beta T-cell receptor nucleic acids encoding these, and their use |
| 09/12/2002 | DE10109618A1 Modifying antigen-presenting cells, useful e.g. in antitumor vaccines, by transfer to them of antigen-containing membrane fragments from diseased cells |
| 09/12/2002 | CA2445013A1 Polypeptides of an hdm2 protein-specific murine alpha/beta t-cell receptor, nucleic acids encoding these and their use |
| 09/12/2002 | CA2445004A1 Polypeptides of a p53 protein-specific murine alpha/beta t-cell receptor, nucleic acids encoding these and their use |
| 09/12/2002 | CA2439929A1 Modified protamine with reduced immunogenicity |
| 09/12/2002 | CA2439811A1 Method of treating tumor and consignment system of proliferating and processing activated lymphocytes to be used in parallel to pdt |
| 09/12/2002 | CA2439636A1 Mouse cytokine receptor |
| 09/12/2002 | CA2439628A1 Vaccine |
| 09/12/2002 | CA2439205A1 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | CA2439203A1 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | CA2439200A1 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | CA2439197A1 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | CA2439196A1 Nuclear hormone receptor ligand binding domains |
| 09/12/2002 | CA2439195A1 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | CA2439192A1 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | CA2438623A1 Extracorporeal blood processing information management system |
| 09/12/2002 | CA2435277A1 Chimeric polypeptides of serum albumin and uses related thereto |
| 09/12/2002 | CA2431500A1 Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses |
| 09/11/2002 | EP1239032A1 Lactic acid bacteria as agents for treating and preventing allergy |
| 09/11/2002 | EP1238694A2 Device and method for depletion of the leukocyte content of blood and blood components |
| 09/11/2002 | EP1238671A1 Cord blood banks and uses thereof |
| 09/11/2002 | EP1238281A2 Cancer associated antigens and uses therefor |
| 09/11/2002 | EP1238095A2 Compositions and methods for caspase-induced apoptosis |
| 09/11/2002 | EP1238092A2 Bovine immunodeficiency virus (biv) based vectors |
| 09/11/2002 | EP1238080A2 Bcl-g polypeptides, encoding nucleic acids and methods of use |
| 09/11/2002 | EP1238077A1 Tnfr/opg-like molecules and uses thereof |
| 09/11/2002 | EP1238066A2 Masp-3, a complement-fixing enzyme, and uses for it |
| 09/11/2002 | EP1238060A1 Method for production of a skin graft and the graft produced thereby |
| 09/11/2002 | EP1238059A2 Long-term cell culture compositions and genetically modified animals derived therefrom |
| 09/11/2002 | EP1237916A2 Ing2, an iaps associated cell cycle protein, compositions and methods of use |
| 09/11/2002 | EP1237582A2 Methods for introducing genes into mammalian subjects |
| 09/11/2002 | EP1237578A2 Micro-cluster liquids and methods of making and using them |
| 09/11/2002 | EP1237564A1 Inducing cellular immune responses to p53 using peptide and nucleic acid compositions |
| 09/11/2002 | EP1237561A2 Use of honey in medical dressings |
| 09/11/2002 | EP1237560A2 Regenerative adjuvant (3-way tap) |
| 09/11/2002 | EP1093393A4 Method and apparatus for magnetically separating selected particles, particularly biological cells |
| 09/11/2002 | EP1073444A4 A food composition and method of using same |
| 09/11/2002 | EP1017406B1 Bovine excretion extracts having anticancer and anti-inflammatory activity and process for preparing the same |
| 09/11/2002 | EP0989854A4 Compositions useful as fibrin sealants |
| 09/11/2002 | EP0765159B1 Spin encapsulation apparatus and method of use |
| 09/11/2002 | CN1369005A New bifidobacteria preventing diarrhea caused by pathogenic bacteria |
| 09/11/2002 | CN1368888A Anti-human mitochondrial a denylate kinase isozyme antibody, diagnostic formulation and diagnostic kit for cardiac disaese |
| 09/11/2002 | CN1368885A Compositions and methods for identifying antigens which elicit an immune response |
| 09/11/2002 | CN1368853A Prophylactic dietary supplement based on milk |
| 09/11/2002 | CN1368391A Yongquan acupoint bag for helping proconception |
| 09/11/2002 | CN1368371A Composite Chinese medicine for gynopathy |
| 09/11/2002 | CN1368370A Composite Chinese medicine applied via rectum and vagina musosa for gynopathy |
| 09/11/2002 | CN1368369A Medicine for treating algia disease and its preparing process |
| 09/11/2002 | CN1368173A Tonglinxiaozheng Particles for treating carcinoma of urinary bladder and its preparing process |
| 09/11/2002 | CN1368172A Qibeifeian particles for treating cancer of lung and its preparing process |
| 09/11/2002 | CN1368055A Venine product for treating rheumatic and rheumatoid arthritis |
| 09/11/2002 | CN1368054A Process for preparing soft body of pearl shell as Chinese-medicinal material |
| 09/11/2002 | CN1368053A Nano medicine 'Zhenshiming' and its preparing process |
| 09/11/2002 | CN1368017A Formula and process for preparing health-care animal's placenta extract |
| 09/11/2002 | CN1090507C Novel pharmaceutical application of nonimmunogenproteinic material and composition |
| 09/11/2002 | CN1090505C 多功能酶 Multifunctional enzyme |
| 09/11/2002 | CN1090504C Chinese medicine preparation for curing hyperplasia of mamary glands and its preparation method |
| 09/11/2002 | CN1090503C Medical capsule for treating rheumatism and building up body and its preparing process |
| 09/11/2002 | CN1090501C Chinese drugs for treating carcinosis |
| 09/11/2002 | CN1090500C Medicine for treating gynaecdogic pelvic tumour and preparation method thereof |
| 09/11/2002 | CN1090494C Medicine for treating aplastic anemia acute granulocytic leukemia and chronic granulocytic leukemia |
| 09/11/2002 | CN1090493C Chiense medicine preparation for pulmonary tuberculosis and its preparation method |
| 09/11/2002 | CN1090491C Oxygen-making up and stamina-strenthening liquid |
| 09/11/2002 | CN1090489C Anti-fatigue farmaceutical and its prepn. process |
| 09/11/2002 | CN1090488C Pharmaceutical for treating diabetes, and its prepe process |
| 09/11/2002 | CN1090486C Chinese patent medicine for treating cancer metastasis |
| 09/11/2002 | CN1090484C Eye drops for curing electric ophthalimia |
| 09/11/2002 | CN1090478C Preparations |
| 09/10/2002 | US6448376 Two new proteins which appear to be new members of the e2f gene family, called e2f-5 |
| 09/10/2002 | US6448231 Presynaptic neurotoxin such as botulinum toxin a |
| 09/10/2002 | US6448076 Method for chemically acellularizing a biological tissue sample |
| 09/10/2002 | US6448054 Locally administering to a specific site a fugetactic agent in an amount effective to repel immune cells |
| 09/10/2002 | US6448045 Expressing a pdx-1 gene in cells that have been cultured under conditions such that the cells are in contact with other cells in the culture; contacting the cells with a glp-1 receptor agonist, thereby inducing insulin gene expression |
| 09/10/2002 | US6447808 Pharmaceutical or veterinary composition for treating wounds comprising milk product extracts including growth factors with basic to neutral isoelectric points |
| 09/10/2002 | US6447784 Genetically engineered salmonella for use in the treatment of cancer |
| 09/10/2002 | US6447783 Compositions comprising FGF9 and use thereof for stimulating cartilage and bone repair |
| 09/10/2002 | US6447780 Administering heat shock proteins (hsp) complexed with antigens; antigrowth agents or development inhibitors for cancer; immunology; vaccines |
| 09/10/2002 | US6447777 Polymerized staphylococcal protein a for treatment of diseases |
| 09/10/2002 | US6447769 Modified tumor cells to inhibit transforming growth factor |
| 09/10/2002 | US6447767 Delay or prevent tumor growth |
| 09/10/2002 | US6447765 Use of cytokines and mitogens to inhibit graft versus host disease |
| 09/10/2002 | CA2163218C New macrophages, process for preparing the same and their use as active substances of pharmaceutical compositions |
| 09/10/2002 | CA2083171C Antasthmatic |
| 09/06/2002 | WO2002068654A2 Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus |
| 09/06/2002 | WO2002068650A2 Modified and stabilized gdf propeptides and uses thereof |
| 09/06/2002 | WO2002068635A2 Methods of inhibiting expression of a target gene in mammalian cells |
| 09/06/2002 | WO2002068627A2 Vector constucts |
| 09/06/2002 | WO2002068614A2 Interferon regulatory factor-1/human estrogen receptor fusion protein and its use for treating carcinomas |
| 09/06/2002 | WO2002068469A2 Modified thrombopoietin with reduced immunogenicity |
| 09/06/2002 | WO2002067986A2 Symbiotic regenerative agent |
| 09/06/2002 | WO2002067978A1 Chondrogenic potential of human bone marrow-derived cd105+ cells by bmp |
| 09/06/2002 | WO2002067973A1 Compositions and methods for protecting tissues and cells from damage, and for repairing damaged tissues |
| 09/06/2002 | WO2002067971A2 Use of endostatin in the treatment of ocular neovascularization |
| 09/06/2002 | WO2002067958A1 Method for determining efficacy of reverse cholesterol transport enhancing agents |
| 09/06/2002 | WO2002067957A1 Use of defibrinated blood for manufacture of a hemoglobin-based oxygen carrier |
| 09/06/2002 | WO2002067956A2 Method for purifying a biological composition |
| 09/06/2002 | WO2002067867A2 Rapid preparation of stem cell matrices for use in tissue and organ treatment and repair |
| 09/06/2002 | WO2002067863A2 Tolerogenic antigen presenting cells and in treating immune-inflammatory conditions |
| 09/06/2002 | WO2002067862A2 Regulation of the ctl response by macrophage migration inhibitory factor |